GlobalData tracks 184 drugs in development for Respiratory Syncytial Virus (RSV) Infections by 144 companies/universities/institutes. The top development phase for Respiratory Syncytial Virus (RSV) Infections is preclinical, with 92 drugs in that stage.
Source link
#Respiratory #Syncytial #Virus #RSV #Infections #drugs #development
